Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, July 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 54 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen: Prostate cancer (hormone relapsed, metastatic) - enzalutamide (after docetaxel): evaluation report

Cited by National Institute for Health and Care Excellence on 18 Oct 2013

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.